Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine

The University of Texas System (UT)

Status and phase

Enrolling

Phase 4

Conditions

Anesthesia

Treatments

Drug: Modified Time Principle Induction (MTPI) with rocuronium

Drug: RSI succinylcholine

Study type

Interventional

Funder types

Other

Identifiers

NCT06029049

HSC-MS-23-0468

Details and patient eligibility

About

The purpose of this study is to assess and compare conditions for tracheal intubation obtained with modified time principal induction with 0.6 mg/kg rocuronium and 1 mg/kg succinylcholine. Specifically, the investigators will be evaluating ease of laryngoscopy, vocal cord view, vocal cord opening, and movement of limbs and coughing during tracheal intubation in order to assess intubation conditions, to compare efficiency and success rate of tracheal intubation between two induction agents and to determine the rate of patient awareness during induction and post-operative recall of paralysis.

Enrollment

152 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

BMI > 30kg/m2 or Mallampati class III or IV.
Requiring general anesthesia and endotracheal intubation

Exclusion criteria

Acute and chronic respiratory disorders, including Chronic obstructive pulmonary disease(COPD) and asthma.
The American Society of Anesthesiologists (ASA) physical status classification > III.
Patients requiring awake intubation.
Pregnant women.
Untreated ischemic heart disease.
Patients requiring an induction dose of propofol < 1 mg/kg.
Allergy to propofol, rocuronium, succinylcholine, or sugammadex.
Patients with renal failure and unknown potassium (K+) level, or patients with K+ level > 5.0
Personal history of malignant hyperthermia (MH), or family history of MH
Patients with suspected or diagnosed neuromuscular disease, patients with burn injuries